• Mental Health

The future of schizophrenia research

Part 9 of Schizophrenia.

This is an exciting time for .

The outlook for people with schizophrenia has improved during the last 30 years or so. Although there still is no cure, effective treatments have been developed, and many people with schizophrenia improve enough to lead independent, satisfying lives.

This is an exciting time for schizophrenia research. The explosion of knowledge in genetics, neuroscience, and behavioral research will enable a better understanding of the causes of the , how to prevent it, and how to develop better treatments to allow those with schizophrenia to achieve their full potential.

How can a person participate in schizophrenia research?

Scientists worldwide are studying schizophrenia so they will be able to develop new ways to prevent and treat the disorder. The only way it can be understood is for researchers to study the illness as it presents itself in those who suffer from it. There are many different kinds of . Some require that medication be changed; others, like genetic , require no change at all in medications.

To receive online information about federally and privately supported schizophrenia research, visit clinicaltrials.gov…. This site descr ibes an extensive list of studies being conducted across the . The information provided should be used in conjunction with advice from a health care professional.

NIMH conducts a Schizophrenia Research Program, which is located at the National Institute of Mental Health in Bethesda, Maryland. Travel assistance and study compensation are available for some studies. A list of outpatient and inpatient studies conducted at NIMH can be found at patientinfo.nimh.nih.gov…. In addition, NIMH staff members can speak with you and help you determine whether their current studies are suitable for you or your family member. Simply call the toll free line at 1-888-674-6464. You can also indicate your interest in research participation by sending an email to [email protected] All calls remain confidential.